 | ||||||
| Financial Markets | ||||||
| NEWS | ||||||
| Trump orders big tariffs on steel, aluminum; roiling markets President Donald Trump speaks during a meeting with steel and aluminum executives in the Cabinet Room of the White House, Thursday, March 1, 2018, in Washington. From left, Roger Newport of AK Steel, John Ferriola of Nucor, Trump, Dave Burritt of U.S. Steel Corporation, and Tim Timkin of Timken ...
| ||||||
| Markets fret over trade war after Trump's tariff vow People walk by an electronic stock board of a securities firm in Tokyo, Friday, March 2, 2018. Asian shares posted steep declines Friday, adding to global stock market losses after President Donald Trump vowed to impose stiff steel and aluminum tariffs, sparking fears of a trade war.Koji Sasahara / AP.
| ||||||
| Here's why Trump's tariffs spooked markets around the world HONG KONG (CNNMoney) - The whiff of a trade war has prompted sharp falls in Asian stock markets. Japan's Nikkei dropped 2.5% on Friday after President Trump alarmed countries around the world by announcing heavy tariffs on steel and aluminum imports. The Hang Seng in Hong Kong slid 1.5%.
| ||||||
| WEB | ||||||
| 2019 - Financial Product Analytics and Sales - Japanese Speaker In a world where information matters, Bloomberg gives influential decision makers a competitive edge. Our core product is the Bloomberg Professional Service, or "the Terminal." Each day, the Terminal powers more than 320,000 subscribers globally to move markets. But to keep connecting our clients to ...
| ||||||
| Exchanges Have Democratized Data, Lowered Costs However, a few Wall Street firms and their trade association, the Securities Industry and Financial Markets Association (SIFMA), are rehashing old arguments that stock exchanges are unfairly profiting from the sale of this data. The truth is a bit different. Edward S. Knight, Nasdaq's General Counsel since ...
| ||||||
| Tocagen to Report Fourth Quarter and Full Year 2017 Financial Re ... March 1, 2018 /PRNewswire/ -- Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced it will report its fourth quarter and full year 2017 financial results and operational progress on Thursday, March 8, 2018, after the close of the U.S. financial markets.
| ||||||
| See more results | Edit this alert | ||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment